Indications
Xydalba is indicated for the treatment of acute bacterial skin and skin structure infections (ABSSSI) in adults and paediatric patients from birth (see sections 4.4 and 5.1).Consideration should be given to official guidance on the appropriate use of antibacterial agents.
Composition
- Active substance
- dalbavancin hydrochloride
- International name (INN)
- dalbavancin
Official product information
The European public assessment report holds the summary of product characteristics and the package leaflet in every EU language.
Prognia shows this product information for reference and learning. It is not treatment advice and can lag behind the official text. Always check the current product information and local protocols before prescribing.
At a glance
- Medicine
- Xydalba
- Active substance
- dalbavancin hydrochloride
- ATC code
- J01XA04
- Therapeutic area
- Soft Tissue Infections, Skin Diseases, Bacterial